
Catalysis science and technology p. 5916 - 5926 (2016)
Update date:2022-08-11
Topics:
Lieu, Thien N.
Nguyen, Khoa D.
Le, Dung T.
Truong, Thanh
Phan, Nam T. S.
An iron-based metal-organic framework, Fe3O(BPDC)3, was synthesized, and was characterized by X-ray powder diffraction (XRD), scanning electron microscopy (SEM), transmission electron microscopy (TEM), thermogravimetric analysis (TGA), Fourier transform infrared (FT-IR) spectroscopy, atomic absorption spectrophotometry (AAS), and nitrogen physisorption measurements. The Fe-MOF could be used as an efficient heterogeneous catalyst for the synthesis of coumarins from salicylaldehydes and activated methylene compounds in the presence of tert-butyl hydroperoxide as the oxidant under base-free conditions. The Fe3O(BPDC)3 was more catalytically active for the synthesis of coumarins than other MOFs such as Cu2(BDC)2(BPY), Cu3(BTC)2, Cu2(BDC)2(DABCO), Ni2(BDC)2(DABCO), and Fe3O(BDC)3. This Fe-MOF also offered significantly higher catalytic activity for the transformation than that of common metal salts such as FeCl3, Fe(NO3)3, FeSO4, CuCl2, CuCl, Cu(NO3)2, and Ni(NO3)2. The Fe3O(BPDC)3 catalyst could be recovered and reused several times without significant degradation in catalytic activity. To the best of our knowledge, the oxidant-promoted formation of coumarins under heterogeneous catalysis conditions was not previously mentioned in the literature.
View More
Tangshan Wisdom Trading Co.,Ltd
Contact:86 315 2222979
Address:No.41 BeiXinXi Road, Yangguang building 1-1102 , Tangshan, Hebei, China
Shandong Hongxiang Zinc Co., Ltd
Contact:086-0311-66187879
Address:DaWang developing zone
Huzhou City Linghu Xinwang Chemical Co.,Ltd.
Contact:86-572-3948695/3945236
Address:huzhou
Beijing Top Science biological technology co., LTD
Contact:+86-13439059536
Address:15-1705 jre three mile, Beijing 100000,CHINA
Shanghai Yurui Biotechnology(Anyang) Pharmaceutical Co., Ltd
Contact:+86-0372-3662335 +86-0372-3661988
Address:hanling industrial park anyang
Doi:10.1002/zaac.19976230808
(1997)Doi:10.1002/ardp.19843171113
(1984)Doi:10.1016/S0960-894X(99)00570-3
(1999)Doi:10.1039/c9ob01370a
(2019)Doi:10.7164/antibiotics.48.12
(1995)Doi:10.1021/ja01136a049
(1952)